Pallas Health vs Hers: Brand vs Compounded GLP-1 Options Compared
Quick verdict: For Pallas Health vs Hers, choose Pallas if you want a clinician to select between FDA-approved pens or compounded semaglutide/tirzepatide and a lower compounded intro price; choose Hers if you want only FDA-approved Wegovy without compounded alternatives and do not need compounding.
How these programs differ at a glance
This Pallas Health vs Hers comparison focuses on the most distinctive supported differences: medication type offered, pricing and billing model, membership and plan structure, clinical review and availability, and shipping or refill logistics. The early verdict above summarizes the core distinction: Pallas offers both brand-name and clinician-personalized compounded options; Hers offers FDA-approved Wegovy only and requires a membership to access medication.
Medication offerings: brand-name versus compounded options
Pallas Health: a US-licensed clinician reviews your history and personalizes a plan that may include FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro, or compounded semaglutide and tirzepatide prepared in the USA when a brand medication is not the right fit. The source states compounded medications are prepared by US-licensed compounding pharmacies and that compounded medications are not FDA-approved and are not generic versions of brand-name drugs.
Hers: offers FDA-approved Wegovy brand-name semaglutide only and explicitly does not offer compounded medications. The source notes Ozempic is FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss at a clinician’s discretion, and reiterates Wegovy and Zepbound are FDA-approved for weight loss.
View Hers plans starting at $149
Pricing and billing differences
Pallas Health: Compounded semaglutide is $139 for the first month, then $597 every 12 weeks which the source frames as a $199 per month average. Compounded tirzepatide is $179 first month, then $897 every 12 weeks ($299 per month average). Brand-name Wegovy, Ozempic, Zepbound and Mounjaro are listed as cash-pay monthly amounts on the source. Pallas is cash-pay only and does not bill insurance.
Hers: Lists Wegovy from $149 per month and injectable semaglutide from $199 per month in captured landing content. The source clearly states an active Hers Weight Loss Membership is required to access medication and that medication and membership are billed separately. The membership fee example given is $39 for the first month, auto-renews at $149 per month thereafter. The source warns that medication is not available without an active membership and that a prescription is not guaranteed.
Care model, clinician review and state availability
Pallas Health: Care is 100% online with a US-licensed clinician reviewing eligibility. The plan price includes provider care, ongoing check-ins and care-team messaging with no membership fee. Pallas notes asynchronous care in most states and that a video visit is required in seven states plus Washington, D.C. Pallas also states care-team hours are weekdays 9 AM to 5 PM ET and no emergency services are offered.
Hers: Offers a personalized care team with ongoing dose check-ins. The source notes treatments are available only when a licensed clinician determines it is medically appropriate and that services are not available in all 50 states. Hers requires confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.
Start clinician review with Pallas
Shipping, refills and plan logistics
Pallas Health: Free expedited and discreet shipping is included on every plan. Compounded plans renew every 12 weeks, so Pallas advises confirming renewal timing at checkout. Pallas allows self-serve portal refills, plan changes, provider messaging and cancel-anytime access and states they refund in full if a clinician decides treatment is not right for you.
Hers: The captured content does not include explicit shipping details or refill portal information. It does emphasize membership and separate billing for medication and membership, and cautions that medication availability and eligibility are clinician-determined and not guaranteed. The source does not supply routine shipping or refill promises similar to Pallas.
Comparison table: Pallas Health vs Hers
| Criteria | Pallas Health | Hers |
|---|---|---|
| Medication types | FDA-approved pens or clinician-personalized compounded semaglutide/tirzepatide | FDA-approved Wegovy only; no compounded medications |
| Intro price cited | Compounded semaglutide $139 first month | Wegovy from $149/mo |
| Renewal/billing model | Compounded plans renew every 12 weeks ($199/mo avg for semaglutide); brand-name cash-pay monthly | Medication price plus required membership billed separately; membership required to access medication |
| Care included | Provider care, check-ins and messaging included in plan price; no membership fee | Personalized care team and dose check-ins; membership required |
| Shipping and logistics | Free expedited and discreet shipping on every plan; compounded in the USA | Shipping details not supplied in captured evidence; availability varies by state |
Pallas Health vs Hers: final take and how to choose
In this Pallas Health vs Hers comparison the main tradeoff is clear. Pallas gives clinician-selected access to either FDA-approved pens or US-compounded semaglutide/tirzepatide with a lower compounded intro price and plan-inclusive provider care but notes the regulatory status that compounded medications are not FDA-approved. Hers limits offerings to FDA-approved Wegovy with no compounded alternative and requires an active membership to receive medication and billing for both membership and medication.
Choose Pallas Health if you want a clinician to decide between brand-name pens and a US-compounded alternative, prefer an all-in plan price that includes provider care and check-ins, and value a lower starting cost for compounded semaglutide ($139 first month then $597 per 12 weeks).
Choose Hers if you want only FDA-approved Wegovy and prefer a provider that does not offer compounded medications, while accepting that medication access requires an active membership and separate billing for medication and membership.